Short-term exercise training prevents micro- And macrovascular disease following coronary stenting

Journal of Applied Physiology

Volumn 108, Issue 6, 2010, Pages 1766-1774

  Long, Xin ^a   Bratz, Ian N ^b   Alloosh, Mouhamad ^a   Edwards, Jason M ^a   Sturek, Michael ^a  

^a INDIANA UNIVERSITY   (United States)

^b Northeast Ohio Medical University   (United States)

Author keywords

Exercise; Hyperlipidemia; Microvessel; Restenosis; Yucatan swine

Indexed keywords

ANIMAL; ARTICLE; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; EXERCISE; KINESIOTHERAPY; MALE; METHODOLOGY; MICROVASCULATURE; PATHOPHYSIOLOGY; STENT; SWINE; PROCEDURES;

ANIMALS; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; EXERCISE THERAPY; MALE; MICROVESSELS; PHYSICAL EXERTION; STENTS; SWINE;

EID: 77953146982     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01014.2009     Document Type: Article

References (61)

1. Beaver BV, Reed W, Leary S, McKiernan B, Bain F, Schultz R, Bennett BT, Pascoe P, Shull E, Cork LC, Francis-Floyd R, Amass KD, Johnson R, Schmidt RH, Underwood W, Thornton GW, Kohn B. 2000 Report of the AVMA panel on euthanasia. JAMA 218: 669-696, 2001.
2. Belardinelli R, Georgiou D, Ginzton L, Cianci G, Purcaro A. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 97: 553-561, 1998.
3. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: The ETICA trial. J Am Coll Cardiol 37: 1891-1900, 2001.
4. Best PJM, McKenna CJ, Hasdai D, Holmes DR Jr, Lerman A. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation 99: 1747-1752, 1999.
5. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 356: 830-840, 2007.
6. Committee to Develop a Resource Book for Animal Exercise Protocols. Resource Book for the Design of Animal Exercise Protocols. Bethesda, MD: Am. Physiol. Soc., 2006.
7. Conn E, Williams RS, Wallace AG. Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function. Am J Cardiol 49: 296-300, 1982.
8. Demacker PN, Hessels M, Toenhake-Dijkstra H, Baadenhuijsen H. Precipitation methods for HDL-C measurement compared, and final evaluation under routine operating conditions of a method with a low sampleto-reagent ratio. Clin Chem 43: 663-668, 1997.
9. Dixon JL, Shen S, Vuchetich JP, Wysocka E, Sun G, Sturek M. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res 43: 1618-1629, 2002.
10. Dyson M, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
11. Dyson M, Mokelke EA, Vuchetich J, Sturek M. Use of computed tomography to evaluate intra-abdominal fat stores in a swine model of the metabolic syndrome (abstract). FASEB J 19: A191, 2005.
12. 1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Coron Artery Dis 19: 27-31, 2008.
13. 2+ entry associated with, metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 85: 631-640, 2010.
14. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89: 2519-12514, 1994.
15. Ehsani AA, Heath GW, Hagberg JM, Sobel BE, Holloszy JO. Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation 64: 1116-1124, 1981.
16. Feuerstein GZ. Restenosis: basic research and clinical perspective. In: Restenosis: From Genetics to Therapeutics, edited by Feuerstein GZ. New York: Dekker, 1997, p. 1-4.
17. Fleenor BS, Bowles DK. Exercise training decreases the size and alters the composition of the neointima in a porcine model of percutaneous transluminal coronary angioplasty (PTCA). J Appl Physiol 107: 937-945, 2009.
18. Gilligan DM, Guetta V, Panza JA, García CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 90: 35-41, 1994.
19. Gregorini L, Marco J, Farah B, Bernies M, Palombo C, Kazakova M, Bossi IM, Cassagneau B, Fajadet J, Di Mario C, Albiero R, Cugno M, Grossi A, Heusch G. Effects of selective α1- and α2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106: 2901-2907, 2002.
20. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu JT, Adams V, Niebauer J, Schuler G. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98: 2709-2715, .1998.
21. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease. Circulation 109: 1371-1378, 2004.
22. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schüler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342: 454-460, 2000.
23. 2+ ATPase uptake is impaired in coronary smooth muscle distal to chronic occlusion. Am J Physiol Heart Circ Physiol 281: H223-H231, 2001.
24. Hinsehen AK, Rose'meyer RB, Headrick JP. Age-related changes in adenosine-mediated relaxation of coronary and aortic smooth muscle. Am J Physiol Heart Circ Physiol 280: H2380-H2389, 2001.
25. Hofman-Bang C, Lisspers J, Nordlander R, Nygren A, Sundin O, Ohman A, Ryden L. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J 20: 1465-1474, 1999.
26. Hosokawa S, Hiasa Y, Takahashi T, Itoh S. Effect of regular exercise on coronary endothelial function in patients with recent myocardial infarction. Circulation 67: 221-224, 2003.
27. Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 98: 1291-1296, 1998.
28. Kern MJ, Puri S, Bach RG, Donohue TJ, Dupouy P, Caracciolo EA, Craig WR, Aguirre F, Aptecar E, Wolford TL, Mechem CJ, DuboisRande JL. Abnormal coronary flow velocity reserve after coronary artery stenting in patients. Role of relative coronary reserve to assess potential mechanisms. Circulation 100: 2491-2498, 1999.
29. Kern MJ. Attenuated coronary collateral function after drug-eluting stent implantation: A new downside of drug-eluting stents? J Am Coll Cardiol 49: 21-22, 2007.
30. Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, Kim EJ, Rha SW, Park CG, Oh DJ. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a Zotarolimus- versus a Sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol. 53: 1653-1659, 2009.
31. Kubo H, Yano K, Hirai H, Yabuki S, Machii K. Preventive effect of exercise training on recurrent stenosis after percutaneous transluminal angioplasty (PTCA). Jpn Circ J 56: 413-421, 1992.
32. 2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic swine are prevented by atorvastatin. J Pharmacol Exp Ther 306: 132-140, 2003.
33. Leung W, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 341: 1496-1500, 1993.
34. Levine GN, Keaney JR Jr, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 332: 512-521, 1995.
35. Lincoff AM, Califf RM, Topol EJ. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 35: 1103-1115, 2000.
36. Linxue L, Nohara R, Makita S, Hosokawa R, Hata T, Okuda K, Hamazaki H, Fujita M, Sasayama S. Effects of long-term exercise training on regional myocardial perfusion changes in patients with coronary artery disease. Jpn Circ J 63: 73-78, 1999.
37. Lloyd PG, Sheehy AF, Edwards JM, Mokelke EA, Sturek M. Leukemia inhibitory factor is upregulated in coronary arteries of Ossabaw miniature swine after stent placement. Coran Artery Dis 19: 217-226, 2008.
38. Maddahi J, Garcia EV, Berman DS, Waxman A, Swan H, Forrester J. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201. Circulation 64: 924-935, 1981.
39. Meier P, Zbinden R, Togni M, Wenaweser P, Windecker S, Meier B, Seiler C. Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 49: 15-20, 2007.
40. Mobius-Winkler S, Hollriegel R, Schuler G, Adams V. Endothelial progenitor cells: implications for cardiovascular disease. Cytometry A 75: 25-37, 2009.
41. + current. Am J Physiol Heart Circ Physiol 288: H1233-H1241, 2005.
42. Monnink S, Tio R, Veeger N, Amoroso G, Van Boven AJ, Van Gilst WH. Exercise-induced ischemia after successful percutaneous coronary intervention is related to distal coronary endothelial dysfunction. J Investig Med 51: 221-226, 2003.
43. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
44. National Research Council. Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. Washington, DC: National Academy Press, 2003.
45. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH. An overview of randomized trials of rehabilitation, with exercise after myocardial infarction. Circulation 80: 234-244, 1989.
46. Pasquali S, Alexander K, Coombs L, Lytle B, Peterson E. Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 145: 445-451, 2003.
47. Pitkänen OP, Nuutila P, Raitakari OT, Porkka K, Lida H, Nuotio I, Rönnemaa T, Viikari J, Taskinen MR, Ehnholm C, Knuuti J. Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation 99: 1678-1684, .1999.
48. Pitkänen OP, Raitakari OT, Niinikoski H, Nuutila P, Lida H, VoipioPulkki LM, Härkönen R, Wegelius U, Rönnemaa T, Viikari J, Knuuti J. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 28: 17 05-1711, 1996.
49. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 84: 1426-1436, 1991.
50. Prati F, Pawlowski T, Gil R, Labellarte A, Gziut A, Caradonna E, Manzoli A, Pappalardo A, Burzotta F, Boccanelli A. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: A major role of plaque embolization?: A serial intravascular ultrasound study. Circulation 107: 2320-2325, 2003.
51. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 23: 833-843, 1994.
52. Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel S, Hauer K, Kttbler W. Myocardial perfusion and regression, of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 19: 34-42, 1992.
53. Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, Drinkmann A, Bacher F, Grunze M, Kübier W. Regular physical exercise and low-fat diet: Effects on progression of coronary artery disease. Circulation 86: 1-11, 1992.
54. Schwartz R, Pearson TA, Kalaria V, Mackin M, Williford DJ, Awasthi A, Shah A, Rains A, Guido J. Prospective serial evaluation of myocardial perfusion and lipids during first six months of prvastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol 42: 600-610, 2003.
55. Sturek M, Alloosh M, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL Jr. Ossabaw island miniature swine: cardiometabolic syndrome assessment. In: Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques, edited by Swindle MM. Boca Raton, FL: CRC, 2007, p. 397-402.
56. Taner CB, Severson SR, Best PJM, Lerman A, Miller VM. Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia. J Appl Physiol 90: 816-820, 2001.
57. Thompson PD. The benefits and risks of exercise training in patients with chronic coronary artery disease. JAMA 259: 1537-1540, 1988.
58. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332: 481-487, 1995.
59. Van Liebergen RAM, Piek JJ, Koch KT, De Winter RJ, Lie KI. Immediate and long-term effect of balloon angioplasty or stent implantation on the absolute and relative coronary blood flow velocity reserve. Circulation 98: 2133-2140, 1998.
60. Weisbrod RM, Griswold MC, Du Y, Bolotina VM, Cohen RA. Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide. Arterioscler Thromb Vase Biol 17: 394-402, 1997.
61. Werner GS, Emig U, Bahrmann P, Ferrari M, Figulla HR. Recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion. Heart 90: 1303-1309, 2004.